Skip to main content

Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001805387

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CERE: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2102231+23
Shares157.8M1.26M156.9M+348.7K (+0.2%)
Value$6.67B$53.1M$6.42B−$201.1M (−3.0%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (43)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CERE in Q2 2024
InstitutionSharesValue% of portfolio
Sand Grove Capital Management LLP919,023$37.6M10.99%
Grantham, Mayo, Van Otterloo & Co. LLC508,838$20.8M0.07%
Trium Capital LLP317,731$13.0M4.61%
Jane Street Group, LLC269,948$11.0M0.01%
Davidson Kempner Capital Management LP260,399$10.6M0.18%
Armistice Capital, LLC201,743$8.25M0.22%
Governors Lane LP192,700$7.88M1.22%
Silphium Asset Management Ltd123,314$5.04M2.41%
Eversept Partners, LP110,010$4.50M0.34%
Murchinson Ltd.100,000$4.09M0.88%
Y-Intercept (Hong Kong) Ltd78,576$3.21M0.18%
Boothbay Fund Management, LLC73,395$3.00M0.10%
Alpine Global Management, LLC50,000$2.04M0.36%
Mirae Asset Global ETFs Holdings Ltd.42,761$1.75M0.00%
Glazer Capital, LLC40,000$1.64M0.13%
Treasurer of the State of North Carolina30,010$1.23M0.01%
Virtu Financial LLC25,140$1.03M0.07%
Vazirani Asset Management LLC25,000$1.02M2.19%
Dynamic Technology Lab Private Ltd24,220$990.0K0.11%
FNY Investment Advisers, LLC12,575$514.0K0.35%
Clear Street Markets LLC12,001$491.0K0.19%
Jump Financial, LLC9,268$379.0K0.01%
Crystalline Management Inc.8,918$364.7K0.42%
Xponance, Inc.8,638$353.2K0.00%
Graham Capital Management, L.P.8,417$344.2K0.01%
Point72 (DIFC) Ltd8,089$330.8K0.03%
Laurion Capital Management LP7,361$301.0K0.01%
Simplex Trading, LLC7,051$288.0K0.01%
Two Sigma Securities, LLC6,782$277.3K0.01%
Corton Capital Inc.6,693$273.7K0.14%
Maryland State Retirement & Pension System5,372$219.7K0.00%
CIBC Asset Management Inc5,092$208.2K0.00%
Quinn Opportunity Partners LLC5,000$204.4K0.02%
Macquarie Group Ltd4,285$175.2K0.00%
Thurston, Springer, Miller, Herd & Titak, Inc.3,107$127.0K0.04%
Catalyst Funds Management Pty Ltd2,800$114.5K0.03%
Centaurus Financial, Inc.2,800$114.0K0.01%
Corebridge Financial, Inc.1,372$56.1K0.00%
Russell Investments Group, Ltd.1,128$46.1K0.00%
Beaird Harris Wealth Management, LLC265$10.8K0.00%
Smartleaf Asset Management LLC145$5.87K0.00%
Itau Unibanco Holding S.A.100$4.09K0.00%
TD Private Client Wealth LLC78$3.19K0.00%

Sold out (20)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CERE in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Segantii Capital Management Ltd1,143,426$48.3M
Credit Suisse AG111,634$4.72M